Trading Tilray Inc CFDs on Libertex 

After the law legalising the possession and consumption of cannabis for recreational purposes entered into force in Canada last June, Tilray was the first company in the sector to hold an IPO. Later, the United States Drug Enforcement Administration officially authorised Tilray Inc. to import medical cannabis for testing in California.

A total of 109 million shares of Tilray are listed on the stock exchange. According to the company's plans, Tilray's market capitalisation may increase to $100 billion in the future. In the meantime, this figure is slightly below $10 billion.

In July, Tilray's (TLRY) share price was $17. Today, it changes hands for a bit over $100. At one point, the price exceeded $200, although about a month after the IPO, it was trading for just $20. After that, the price skyrocketed, similarly to the Bitcoin boom. As a result, investors showed increased interest in the sector, which, at that time, was not very actively represented on the market. Later, the rise slowed as the euphoria ebbed, and several other companies in this field entered the market, after which Tilray stock lost its exclusive nature.

Several large companies are currently showing interest in the cannabis market. In particular, Microsoft has entered into a partnership agreement with Kind Financial, a US-based startup that develops software for government agencies controlling the production and sale of cannabis. Coca-Cola has also announced plans to produce drinks that incorporate cannabis.